Maghinay Sr., Romeo R.
HRN: 02-60-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2023
02/12/2023
IV
600mg
Q6
DM Foot Wagner 5
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes